{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T05:29:28Z","timestamp":1786771768767,"version":"build-2736575974"},"reference-count":14,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2026]]},"DOI":"10.70352\/scrj.cr.26-0322","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T22:11:45Z","timestamp":1786745505000},"page":"n\/a","source":"Crossref","is-referenced-by-count":0,"title":["Effective Control of Synchronous Male Breast and Prostate Cancer with Androgen Deprivation Therapy: A Case Report"],"prefix":"10.70352","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6107-1029","authenticated-orcid":false,"given":"Megumi","family":"Furukawa","sequence":"first","affiliation":[{"name":"Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Gondo","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Mitsueda","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Arimura","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Fujiki","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Kawano","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Kanemitsu","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Teraoka","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyo","family":"Ohi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Rai","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Sagara","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Sagara","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Breast and Thyroid Surgical Oncology, Sagara Hospital, Hakuaikai Medical Corporation, Kagoshima, Kagoshima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) White J, Kearins O, Dodwell D, et al. Male breast carcinoma: increased awareness needed. Breast Cancer Res 2011; 13: 219.","DOI":"10.1186\/bcr2930"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Gucalp A, Traina TA, Eisner JR, et al. Male breast cancer: a disease distinct from female breast cancer. Breast Cancer Res Treat 2019; 173: 37\u201348.","DOI":"10.1007\/s10549-018-4921-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Cheng JJ, Shen J, Suresh Y, et al. Synchronous metastatic prostate cancer and male breast cancer while on testosterone replacement therapy: case report. Int J Surg Case Rep 2024; 122: 110050.","DOI":"10.1016\/j.ijscr.2024.110050"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Omata H, Inoue S, Inoue M, et al. A case of simultaneous presence of breast and prostatic cancer. Nihon Rinsho Geka Gakkai Zasshi 2009; 70: 2200\u20135. (in Japanese)","DOI":"10.3919\/jjsa.70.2200"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Tamaki M, Kamio T, Yamaguchi M, et al. A case of male breast cancer that developed during endocrine therapy for prostate cancer. Nihon Rinsho Geka Gakkai Zasshi 2009; 70: 1006\u201310 (in Japanese).","DOI":"10.3919\/jjsa.70.1006"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Lopez M, Natali M, Di Lauro L, et al. Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer. Cancer 1993; 72: 502\u20135.","DOI":"10.1002\/1097-0142(19930715)72:2<502::AID-CNCR2820720228>3.0.CO;2-1"},{"key":"7","unstructured":"7) Woo TC, Choo R, Chander S. An unusual case of concurrent breast and prostate cancer. Can J Urol 2004; 11: 2390\u20132."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Langley RE, Gilbert DC, Duong T, et al. Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. Lancet 2021; 397: 581\u201391.","DOI":"10.1016\/S0140-6736(21)00100-8"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Gucalp A, Tolaney S, Isakoff SJ, et al. Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer. Clin Cancer Res 2013; 19: 5505\u201312.","DOI":"10.1158\/1078-0432.CCR-12-3327"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Elias AD, Spoelstra NS, Staley AW, et al. Phase II trial of fulvestrant plus enzalutamide in ER+\/HER2- advanced breast cancer. NPJ Breast Cancer 2023; 9: 41.","DOI":"10.1038\/s41523-023-00544-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Krop I, Abramson V, Colleoni M, et al. A randomized placebo controlled phase II trial evaluating exemestane with or without enzalutamide in patients with hormone receptor-positive breast cancer. Clin Cancer Res 2020; 26: 6149\u201357.","DOI":"10.1158\/1078-0432.CCR-20-1693"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Cochrane DR, Bernales S, Jacobsen BM, et al. Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide. Breast Cancer Res 2014; 16: R7.","DOI":"10.1186\/bcr3599"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Palmieri C, Linden H, Birrell SN, et al. Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial. Lancet Oncol 2024; 25: 317\u201325.","DOI":"10.1016\/S1470-2045(24)00004-4"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) You CP, Leung MH, Tsang WC, et al. Androgen receptor as an emerging feasible biomarker for breast cancer. Biomolecules 2022; 12: 72.","DOI":"10.3390\/biom12010072"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.26-0322\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T05:23:49Z","timestamp":1786771429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/12\/1\/12_cr.26-0322\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.26-0322","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"cr.26-0322"}}